Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-11 of 11 for your search:
Cancer Type/Condition:
childhood acute promyelocytic leukemia (M3)
Stage/Subtype:
childhood acute promyelocytic leukemia (M3)
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
21 and under
Sponsor:
NCI, Other
Protocol IDs:
AML08
, NCT00703820
2.
Phase III Study of Risk-Adapted Induction Chemotherapy, Risk-Adapted Consolidation Combination Chemotherapy Including Arsenic Trioxide, and Maintenance Combination Chemotherapy in Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
2 to 21
Sponsor:
NCI
Protocol IDs:
COG-AAML0631
, COG-AAML0631, AAML0631, NCT00866918
3.
Phase I/II Study of Alemtuzumab, Bulsulfan, and Cyclophosphamide Followed by HLA-Mismatched Unrelated Peripheral Blood Stem Cell Transplantation in Patients With Hematologic Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
50 and under
Sponsor:
NCI
Protocol IDs:
FHCRC-1981.00
, 6508, NCT00555048
4.
All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab and Theophylline
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2006-0706
, NCT00413166
5.
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
8 to 75
Sponsor:
NHLBI
Protocol IDs:
090087
, 09-H-0087, NCT00859586
6.
Phase I Study of Ixabepilone in Young Patients With Refractory Solid Tumors (Closed to Accrual as of 10/4/2007) or Relapsed or Refractory Leukemia
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
2 to 21
Sponsor:
NCI
Protocol IDs:
NCI-02-C-0031
, 02-C-0031, 5425, NCI-5425, NCT00030108
7.
Phase I Study of Clofarabine Followed by Fractionated Cyclophosphamide in Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or High-Risk Myeloproliferative Disorders
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
2 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J0561
, JHOC-00000845, NCT00293410
8.
Phase I Study of Sorafenib in Pediatric Patients With Relapsed or Refractory Solid Tumors or Leukemia
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
2 to 21
Sponsor:
NCI
Protocol IDs:
COG-ADVL0413
, ADVL0413, NCI-06-C-0233, NCT00343694
9.
Phase I Study of Cediranib in Pediatric Patients With Refractory or Recurrent Extracranial Malignant Solid Tumors or Acute Myeloid Leukemia
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
2 to 18
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
NCI-06-C-0152
, NCI-P6571, NCT00354848, ZENECA-D8480C00016
10.
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
1 to 21
Sponsor:
Other
Protocol IDs:
J0715
, POE07-01, NCT00852709
11.
Pilot Study of Double Umbilical Cord Blood Stem Cell Transplantation in Patients With Hematologic Cancer or Other Diseases
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
Under 70
Sponsor:
NCI
Protocol IDs:
WSU-2006-059
, WSU-112506MP2F, NCT00423826
Select All on Page
Help with Results
